Therefore, insight into the turnover and stability of dystrophin in vivo is essential to determine duration of action effects of dystrophin as this would be important in guiding therapeutic dosing regimens in DMD patients. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.